Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

The global life sciences sector, encompassing bio-pharmaceuticals and medical devices, reached an estimated US$2,000,000 million in 2024, registering 5.3% growth from 2023. This expansion has been ...

While the official figures point to measurable progress, urban planning and road safety experts caution that enforcement-led ...